Search

Wen Huang

Examiner (ID: 19338, Phone: (571)270-0234 , Office: P/2872 )

Most Active Art Unit
2872
Art Unit(s)
2872
Total Applications
956
Issued Applications
765
Pending Applications
100
Abandoned Applications
114

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17830119 [patent_doc_number] => 20220267423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => IGE ANTIBODIES CROSS-REACTIVE TO ALLERGENS AND TUMOR ANTIGENS [patent_app_type] => utility [patent_app_number] => 17/391314 [patent_app_country] => US [patent_app_date] => 2021-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391314 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/391314
IGE ANTIBODIES CROSS-REACTIVE TO ALLERGENS AND TUMOR ANTIGENS Aug 1, 2021 Abandoned
Array ( [id] => 19381230 [patent_doc_number] => 20240271100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => IN VITRO DIFFERENTIATION OF PANCREATIC ENDOCRINE CELLS [patent_app_type] => utility [patent_app_number] => 18/018787 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58940 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -160 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018787 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/018787
IN VITRO DIFFERENTIATION OF PANCREATIC ENDOCRINE CELLS Jul 29, 2021 Pending
Array ( [id] => 17533851 [patent_doc_number] => 20220112460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => NANOCOIL-SUBSTRATE COMPLEX FOR CONTROLLING STEM CELL BEHAVIOR, PREPARATION METHOD THEREOF, AND METHOD OF CONTROLLING ADHESION AND DIFFERENTIATION OF STEM CELL BY USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/443501 [patent_app_country] => US [patent_app_date] => 2021-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8683 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443501 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/443501
NANOCOIL-SUBSTRATE COMPLEX FOR CONTROLLING STEM CELL BEHAVIOR, PREPARATION METHOD THEREOF, AND METHOD OF CONTROLLING ADHESION AND DIFFERENTIATION OF STEM CELL BY USING THE SAME Jul 26, 2021 Abandoned
Array ( [id] => 18164788 [patent_doc_number] => 20230031385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => STORAGE MEDIA FOR PRESERVATION OF CORNEAL TISSUE [patent_app_type] => utility [patent_app_number] => 17/380474 [patent_app_country] => US [patent_app_date] => 2021-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4452 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17380474 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/380474
STORAGE MEDIA FOR PRESERVATION OF CORNEAL TISSUE Jul 19, 2021 Abandoned
Array ( [id] => 19352562 [patent_doc_number] => 12052986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-06 [patent_title] => Portable oxygen source with perfusion system [patent_app_type] => utility [patent_app_number] => 17/305472 [patent_app_country] => US [patent_app_date] => 2021-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5307 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305472 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/305472
Portable oxygen source with perfusion system Jul 7, 2021 Issued
Array ( [id] => 17532271 [patent_doc_number] => 20220110880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => NANOHELIX-SUBSTRATE COMPLEX FOR CONTROLLING MACROPHAGE BEHAVIOR, PREPARATION METHOD THEREOF, AND METHOD OF CONTROLLING ADHESION AND POLARIZATION OF MACROPAGE BY USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/368883 [patent_app_country] => US [patent_app_date] => 2021-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8446 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368883 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/368883
Nanohelix-substrate complex for controlling macrophage behavior, preparation method thereof, and method of controlling adhesion and polarization of macrophage by using the same Jul 6, 2021 Issued
Array ( [id] => 17333764 [patent_doc_number] => 20220000095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => ERYTHROCYTE MEMBRANE COATING [patent_app_type] => utility [patent_app_number] => 17/366187 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366187 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/366187
ERYTHROCYTE MEMBRANE COATING Jul 1, 2021 Abandoned
Array ( [id] => 18567354 [patent_doc_number] => 20230257686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => METHOD FOR PRODUCING CARTILAGE TISSUE [patent_app_type] => utility [patent_app_number] => 18/003737 [patent_app_country] => US [patent_app_date] => 2021-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003737 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/003737
METHOD FOR PRODUCING CARTILAGE TISSUE Jun 30, 2021 Abandoned
Array ( [id] => 18709562 [patent_doc_number] => 20230332182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA [patent_app_type] => utility [patent_app_number] => 18/004151 [patent_app_country] => US [patent_app_date] => 2021-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31292 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -155 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004151 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/004151
COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA Jun 30, 2021 Pending
Array ( [id] => 17314897 [patent_doc_number] => 20210403945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => COMPOSITIONS AND METHODS UTILIZING GENETICALLY-MODIFIED ANIMALS AND CELLS [patent_app_type] => utility [patent_app_number] => 17/356920 [patent_app_country] => US [patent_app_date] => 2021-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23999 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356920 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/356920
COMPOSITIONS AND METHODS UTILIZING GENETICALLY-MODIFIED ANIMALS AND CELLS Jun 23, 2021 Abandoned
Array ( [id] => 17297697 [patent_doc_number] => 20210393536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => METHODS AND COMPOSITIONS RELATED TO EXTRACELLULAR VESICLES [patent_app_type] => utility [patent_app_number] => 17/355290 [patent_app_country] => US [patent_app_date] => 2021-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11234 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17355290 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/355290
METHODS AND COMPOSITIONS RELATED TO EXTRACELLULAR VESICLES Jun 22, 2021 Pending
Array ( [id] => 18673033 [patent_doc_number] => 20230310505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => COMPOSITION FOR PREVENTING HEARING LOSS CONTAINING MESENCHYMAL STEM CELLS OR EXOSOMES DERIVED THEREFROM AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 18/006684 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10013 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006684 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/006684
COMPOSITION FOR PREVENTING HEARING LOSS CONTAINING MESENCHYMAL STEM CELLS OR EXOSOMES DERIVED THEREFROM AS ACTIVE INGREDIENT Jun 20, 2021 Pending
Array ( [id] => 18485182 [patent_doc_number] => 20230212509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTORS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/000008 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -151 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000008 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000008
BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTORS AND USE THEREOF May 27, 2021 Pending
Array ( [id] => 18449544 [patent_doc_number] => 20230190820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => CELL HARVEST METHOD [patent_app_type] => utility [patent_app_number] => 17/927415 [patent_app_country] => US [patent_app_date] => 2021-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12944 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -76 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927415 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/927415
CELL HARVEST METHOD May 26, 2021 Abandoned
Array ( [id] => 18511617 [patent_doc_number] => 20230227787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => MASS PRODUCTION METHOD OF UNIFORM SIZE CELL AGGREGATES [patent_app_type] => utility [patent_app_number] => 17/926971 [patent_app_country] => US [patent_app_date] => 2021-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9155 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926971 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/926971
MASS PRODUCTION METHOD OF UNIFORM SIZE CELL AGGREGATES May 26, 2021 Pending
Array ( [id] => 18436017 [patent_doc_number] => 20230183311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPY [patent_app_type] => utility [patent_app_number] => 17/926374 [patent_app_country] => US [patent_app_date] => 2021-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13611 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926374 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/926374
POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPY May 25, 2021 Pending
Array ( [id] => 17228885 [patent_doc_number] => 20210355441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => GENERATION OF HOXA-EXPRESSING HEMOGENIC ENDOTHELIUM WITH ENHANCED T CELL POTENTIAL FROM HPSCS [patent_app_type] => utility [patent_app_number] => 17/323715 [patent_app_country] => US [patent_app_date] => 2021-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16457 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323715 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/323715
GENERATION OF HOXA-EXPRESSING HEMOGENIC ENDOTHELIUM WITH ENHANCED T CELL POTENTIAL FROM HPSCS May 17, 2021 Pending
Array ( [id] => 17355395 [patent_doc_number] => 20220016191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => SIMULTANEOUS DELIVERY OF CANCER TREATMENT PROGRAMS TO TUMOR AND IMMUNE CELLS [patent_app_type] => utility [patent_app_number] => 17/320965 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320965 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/320965
SIMULTANEOUS DELIVERY OF CANCER TREATMENT PROGRAMS TO TUMOR AND IMMUNE CELLS May 13, 2021 Abandoned
Array ( [id] => 18583132 [patent_doc_number] => 20230265391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => METHODS AND COMPOSITIONS FOR MAKING AND USING ENDOCARDIAL CELLS [patent_app_type] => utility [patent_app_number] => 17/924040 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15065 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924040 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/924040
METHODS AND COMPOSITIONS FOR MAKING AND USING ENDOCARDIAL CELLS May 6, 2021 Pending
Array ( [id] => 17214576 [patent_doc_number] => 20210347913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH [patent_app_type] => utility [patent_app_number] => 17/313121 [patent_app_country] => US [patent_app_date] => 2021-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19190 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313121 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/313121
Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such May 5, 2021 Issued
Menu